TDSGF
Price:
$0.057
Market Cap:
$8.48M
Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. It provides telomere analysis platform with diagnostic and prognostic applications; and solutions with liquid biopsies and related technologies in oncology and neurological diseases. The company's lead application is Telo-MM, a solution that provides actionable information to medical professionals in the treatment of Multiple Myeloma, a form of blood cancer. Its solutions also include TeloView, a proprietary software platform used to quantify specific features of each patient's telomeres. The compan...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2021-01-08
Stock Exchange
PNK
Ticker
TDSGF
According to Telo Genomics Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -1.90. This represents a change of -57.69% compared to the average of -4.49 of the last 4 quarters.
The mean historical PE Ratio of Telo Genomics Corp. over the last ten years is -8.91. The current -1.90 PE Ratio has changed 2.03% with respect to the historical average. Over the past ten years (40 quarters), TDSGF's PE Ratio was at its highest in in the September 2015 quarter at 282.82. The PE Ratio was at its lowest in in the June 2016 quarter at -71.29.
Average
-8.91
Median
-8.08
Minimum
-21.91
Maximum
-1.54
Discovering the peaks and valleys of Telo Genomics Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 351.48%
Maximum Annual PE Ratio = -1.54
Minimum Annual Increase = -87.68%
Minimum Annual PE Ratio = -21.91
Year | PE Ratio | Change |
---|---|---|
2024 | -4.87 | -22.62% |
2023 | -6.29 | -36.69% |
2022 | -9.94 | -54.65% |
2021 | -21.91 | 278.78% |
2020 | -5.78 | 275.88% |
2019 | -1.54 | -84.40% |
2018 | -9.87 | -10.05% |
2017 | -10.97 | 351.48% |
2015 | -2.43 | -84.31% |
2014 | -15.49 | -87.68% |
The current PE Ratio of Telo Genomics Corp. (TDSGF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-7.03
5-year avg
-9.76
10-year avg
-8.91
Telo Genomics Corp.’s PE Ratio is greater than Exact Sciences Corporation (-10.29), greater than Natera, Inc. (-106.09), less than CareDx, Inc (15.12), greater than Illumina, Inc. (-13.33), greater than Twist Bioscience Corporation (-9.39),
Company | PE Ratio | Market cap |
---|---|---|
-10.29 | $10.60B | |
-106.09 | $20.40B | |
15.12 | $896.46M | |
-13.33 | $12.81B | |
-9.39 | $1.80B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Telo Genomics Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Telo Genomics Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Telo Genomics Corp.'s PE Ratio?
How is the PE Ratio calculated for Telo Genomics Corp. (TDSGF)?
What is the highest PE Ratio for Telo Genomics Corp. (TDSGF)?
What is the 3-year average PE Ratio for Telo Genomics Corp. (TDSGF)?
What is the 5-year average PE Ratio for Telo Genomics Corp. (TDSGF)?
How does the current PE Ratio for Telo Genomics Corp. (TDSGF) compare to its historical average?